Filing Details

Accession Number:
0001193125-22-079744
Form Type:
13D Filing
Publication Date:
2022-03-20 20:00:00
Filed By:
Boxer Capital, Llc
Company:
Iteos Therapeutics Inc. (NASDAQ:ITOS)
Filing Date:
2022-03-21
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Boxer Capital 0 3,142,058 0 3,142,058 3,142,058 8.9%
Boxer Asset Management Inc 0 3,142,058 0 3,142,058 3,142,058 8.9%
Aaron I. Davis 9,687 0 9,687 0 9,687 0.03%
Joe Lewis 0 3,142,058 0 3,142,058 3,142,058 8.9%
Filing

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

SCHEDULE 13D

(Rule 13d-101)

Under the Securities Exchange Act of 1934

(Amendment No. 2)*

 

 

iTeos Therapeutics, Inc.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

46565G104

(CUSIP Number)

David A. Brown

Alston & Bird LLP

950 F Street, N.W.

Washington, DC 20004-1404

202-239-3463

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

March 17, 2022

(Date of Event Which Requires Filing of this Statement)

 

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  ☐.

 

*

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 46565G104    SCHEDULE 13D   

 

  1    

  NAMES OF REPORTING PERSONS

 

  Boxer Capital, LLC

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  SOURCE OF FUNDS (See Instructions)

 

  WC

  5  

  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     7    

  SOLE VOTING POWER

 

  0

     8  

  SHARED VOTING POWER

 

  3,142,058

     9  

  SOLE DISPOSITIVE POWER

 

  0

   10  

  SHARED DISPOSITIVE POWER

 

  3,142,058

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  3,142,058

12  

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  8.9%*

14  

  TYPE OF REPORTING PERSON (See Instructions)

 

  OO

 

*

Based on 35,283,580 shares of the Issuers Common Stock outstanding, which is the sum of (i) 35,273,893 shares of the Issuers Common Stock outstanding as of November 2, 2021 as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021 and (ii) 9,687 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 46565G104    SCHEDULE 13D   

 

  1    

  NAMES OF REPORTING PERSONS

 

  Boxer Asset Management Inc.

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  SOURCE OF FUNDS (See Instructions)

 

  AF

  5  

  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Bahamas

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     7    

  SOLE VOTING POWER

 

  0

     8  

  SHARED VOTING POWER

 

  3,142,058

     9  

  SOLE DISPOSITIVE POWER

 

  0

   10  

  SHARED DISPOSITIVE POWER

 

  3,142,058

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  3,142,058

12  

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  8.9%*

14  

  TYPE OF REPORTING PERSON (See Instructions)

 

  CO

 

*

Based on 35,283,580 shares of the Issuers Common Stock outstanding, which is the sum of (i) 35,273,893 shares of the Issuers Common Stock outstanding as of November 2, 2021 as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021 and (ii) 9,687 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 46565G104    SCHEDULE 13D   

 

  1    

  NAMES OF REPORTING PERSONS

 

  Aaron I. Davis

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  SOURCE OF FUNDS (See Instructions)

 

  AF

  5  

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States of America

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     7    

  SOLE VOTING POWER

 

  9,687*

     8  

  SHARED VOTING POWER

 

  0

     9  

  SOLE DISPOSITIVE POWER

 

  9,687*

   10  

  SHARED DISPOSITIVE POWER

 

  0

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  9,687*

12  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  0.03%**

14  

  TYPE OF REPORTING PERSON (See Instructions)

 

  IN

 

*

Represents options exercisable by the Reporting Person within the next 60 days.

**

Based on 35,283,580 shares of the Issuers Common Stock outstanding, which is the sum of (i) 35,273,893 shares of the Issuers Common Stock outstanding as of November 2, 2021 as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021 and (ii) 9,687 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 46565G104    SCHEDULE 13D   

 

  1    

  NAMES OF REPORTING PERSONS

 

  Joe Lewis

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  SOURCE OF FUNDS (See Instructions)

 

  AF

  5  

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United Kingdom

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     7    

  SOLE VOTING POWER

 

  0

     8  

  SHARED VOTING POWER

 

  3,142,058

     9  

  SOLE DISPOSITIVE POWER

 

  0

   10  

  SHARED DISPOSITIVE POWER

 

  3,142,058

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  3,142,058

12  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  8.9%*

14  

  TYPE OF REPORTING PERSON (See Instructions)

 

  IN

 

*

Based on 35,283,580 shares of the Issuers Common Stock outstanding, which is the sum of (i) 35,273,893 shares of the Issuers Common Stock outstanding as of November 2, 2021 as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021 and (ii) 9,687 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 46565G104    SCHEDULE 13D   

 

This Amendment No. 2 (Amendment No. 2) amends and supplements the statement on Schedule 13D filed on August 7, 2020 (the Original Filing) by Boxer Capital, LLC (Boxer Capital), Boxer Asset Management Inc. (Boxer Management), MVA Investors, LLC, Aaron I. Davis, and Joe Lewis, as amended by Amendment No. 1 filed on January 6, 2022. The Original Filing, as amended, remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 2. For purposes of this Amendment No. 2, the Reporting Persons is defined collectively as Boxer Capital, Boxer Management, Mr. Davis and Mr. Lewis. Capitalized terms used and not defined in this Amendment No. 2 have the meanings set forth in the Original Filing, as amended.

 

Item 5.

Interest in Securities of the Issuer.

Item 5 is hereby amended and restated in its entirety as follows:

All percentages are based on 35,283,580 shares of the Issuers Common Stock outstanding, which is the sum of (i) 35,273,893 shares of the Issuers Common Stock outstanding as of November 2, 2021 as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021 and (ii) 9,687 shares of Common Stock subject to options exercisable within the next 60 days.

(a) The Reporting Persons may be deemed to beneficially own, in the aggregate, 3,151,745 shares of Common Stock, representing 8.9% of the outstanding Common Stock.

Boxer Capital, Boxer Management and Joe Lewis beneficially own 3,142,058 shares of Common Stock which represents 8.9% of the outstanding Common Stock. Aaron I Davis beneficially owns 9,687 shares of Common Stock which represents 0.03% of the outstanding Common Stock.

In connection with his service as a director of the Issuer, Aaron I. Davis received from the Issuer grants of options to purchase shares of Common Stock of the Issuer. The table below reflects options to purchase shares of Common Stock of the Issuer owned by Aaron I. Davis that are not currently exercisable within the next 60 days:

 

Grant Date   

Number of

Options Not Exercisable Within
60 Days

   Vesting Schedule

7/23/2020

   6,921    The remainder of the grant will vest in equal monthly installments until the third anniversary of the grant date.

6/17/2021

   16,608    The grant will vest upon the earlier of June 17, 2022 or the next annual meeting of the Issuers stockholders.

(b) With respect to any rights or powers to vote, or to direct the vote of, or to dispose of, or direct the disposition of, the Common Stock owned by the Reporting Persons:

(i) Sole power to vote or direct the vote:

Aaron I. Davis has sole power to vote or to direct the vote of the 9,687 shares of Common Stock he beneficially owns.

(ii) Shared power to vote or to direct the vote:

Boxer Capital, Boxer Management and Joe Lewis have shared power to vote or to direct the vote of the 3,142,058 shares of Common Stock they beneficially own.

(iii) Sole power to dispose or direct the disposition of:

Aaron I. Davis has sole power to dispose or to direct the disposition of the 9,687 shares of Common Stock he beneficially owns.

(iv) Shared power to dispose or to direct the disposition of:


CUSIP No. 46565G104    SCHEDULE 13D   

 

Boxer Capital, Boxer Management and Joe Lewis have shared power to dispose or direct the disposition of the 3,142,058 shares of Common Stock they beneficially own.

(c) Other than as described below, the Reporting Persons have not engaged in any transactions in the Common Stock in the past 60 days.

Boxer Capital effected the following transactions in the Common Stock in the last 60 days:

 

Date    Transaction    Shares of Common Stock    Price Per Share

3/17/2022

   Sale    575,201    $35.25

(d) No other person has the right to receive or the power to direct the receipt of dividends, or proceeds of sale of such securities outlined in this report.

(e) Not applicable.

Item 7. Material to Be Filed as Exhibits.

 

Exhibit 1    Joint Filing Agreement, dated July 31, 2020, among Boxer Capital, Boxer Management, MVA Investors, Aaron I. Davis and Joe Lewis, incorporated by reference to Exhibit 1 to the Schedule 13D filed by the Reporting Persons on August 7, 2020.

CUSIP No. 46565G104    SCHEDULE 13D   

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: March 18, 2022

 

BOXER CAPITAL, LLC
By:  

/s/Aaron I. Davis

Name:   Aaron I. Davis
Title:   Chief Executive Officer
BOXER ASSET MANAGEMENT INC.
By:  

/s/ Jason Callender

Name:   Jason Callender
Title:   Director
AARON I. DAVIS
By:  

/s/ Aaron I. Davis

  Aaron I. Davis, Individually
JOSEPH C. LEWIS
By:  

/s/ Joseph C. Lewis

  Joseph C. Lewis, Individually